Atrium Therapeutics Market Sentiment

Atrium Therapeutics Inc

RNANASDAQ

Trade with Public

$8.00

0.020.25%

Últ. Act.: Oct 21, 4:00 PM

$8.02

0.040.5%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Atrium Therapeutics Market Sentiment - Benzinga

Atrium Therapeutics Market Sentiment

Market sentiment signals for Atrium Therapeutics (RNA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

23 analysts

Options Flow (P/C)

—

0 calls · 1 puts

Avg Consensus PT

$60

+649.4%

Highest Price Target

$96

+1097.0%

Cantor Fitzgerald

Lowest Price Target

$25

+211.7%

HC Wainwright & Co.

Short Interest

6.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 14, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+211.7%	$25 → $25	Maintained	Buy
Aug 6, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+211.7%	$25	Initiate	Buy
Jun 18, 2026	Cantor Fitzgerald	Kristen Kluska—	+211.7%	$25	Initiate	Overweight
May 15, 2026	Leerink Partners	Joseph Schwartz—	+211.7%	$25	Initiate	Outperform
May 1, 2026	HC Wainwright & Co.	Ananda Ghosh—	—	—	Suspends	Neutral
Mar 11, 2026	Wells Fargo	Yanan Zhu—	+211.7%	$25	Initiate	Overweight
Nov 11, 2025	Chardan Capital	Keay Nakae—	+797.8%	$72 → $72	Maintained	Neutral
Oct 29, 2025	TD Cowen	Ritu Baral—	+822.7%	$78 → $74	Downgrade	Buy→Hold
Oct 28, 2025	Chardan Capital	Keay Nakae—	+797.8%	$75 → $72	Downgrade	Buy→Neutral
Oct 28, 2025	RBC Capital	Luca Issi—	+797.8%	$61 → $72	Downgrade	Outperform→Sector Perform
Oct 27, 2025	Citigroup	Geoff Meacham—	+797.8%	$75 → $72	Downgrade	Buy→Neutral
Oct 27, 2025	Leerink Partners	Joseph Schwartz—	+797.8%	$65 → $72	Downgrade	Outperform→Market Perform
Oct 27, 2025	Raymond James	Martin Auster—	—	—	Downgrade	Strong Buy→Market Perform
Oct 27, 2025	Bernstein	William Pickering—	+797.8%	$52 → $72	Downgrade	Outperform→Market Perform
Oct 27, 2025	Needham	Joseph Stringer—	+710.5%	$65 → $65	Downgrade	Buy→Hold
Oct 27, 2025	HC Wainwright & Co.	Ananda Ghosh—	+797.8%	$87 → $72	Downgrade	Buy→Neutral
Sep 22, 2025	Evercore ISI Group	Josh Schimmer—	+710.5%	$70 → $65	Maintained	Outperform
Sep 17, 2025	Roth Capital	Boobalan Pachaiyappan—	+673.1%	$62	Initiate	Buy
Sep 15, 2025	B of A Securities	Geoff Meacham—	+710.5%	$56 → $65	Maintained	Buy
Sep 12, 2025	HC Wainwright & Co.	Ananda Ghosh—	+984.8%	$68 → $87	Maintained	Buy
Sep 10, 2025	Needham	Joseph Stringer—	+710.5%	$60 → $65	Maintained	Buy
Sep 10, 2025	Chardan Capital	Keay Nakae—	+835.2%	$75 → $75	Maintained	Buy
Aug 8, 2025	Wells Fargo	Yanan Zhu—	+835.2%	$70 → $75	Maintained	Overweight
Aug 8, 2025	Barclays	Gena Wang—	+673.1%	$59 → $62	Maintained	Overweight
Aug 8, 2025	Chardan Capital	Keay Nakae—	+835.2%	$75 → $75	Maintained	Buy